TP53 rs121912619: Understanding This Rare Genetic Variant
The rs121912619 variant is a rare, hypomorphic allele located within the TP53 gene. It has been historically misclassified as a high-risk pathogenic variant, though current research suggests it possesses lower penetrance than classic cancer-associated mutations.
What each genotype means
Typical TP53 function
This genotype represents the most common genetic sequence for this location in the TP53 gene. It is considered the baseline state, and there is no evidence suggesting this specific configuration contributes to altered protein function or increased cancer risk.
This is the most common genotype observed across all global populations.
Hypomorphic TP53 variant carrier
This genotype indicates you carry one copy of a variant that is classified as hypomorphic, meaning the p53 protein may retain partial function rather than being completely inactive. While historically associated with cancer risk, current research suggests this variant has low penetrance, meaning it does not guarantee the development of disease. You should discuss these findings with a genetic counselor or physician to understand how this fits into your overall health context.
This genotype is extremely rare, appearing in a very small fraction of the global population according to large-scale genomic databases.
Hypomorphic TP53 variant homozygote
This genotype indicates you carry two copies of a hypomorphic TP53 variant. Research suggests that while this variant results in a partial loss of protein activity, it is distinct from high-penetrance pathogenic mutations that cause severe, early-onset cancer syndromes. Because the clinical implications of this specific homozygous state are complex and not fully understood, it is recommended to consult with a medical geneticist for personalized risk assessment.
This genotype is exceptionally rare and has not been frequently documented in large population studies.
What is rs121912619 and Where is it Located?
The rs121912619 variant is a specific change in the DNA sequence of the TP53 gene. In genomics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. The TP53 gene is located on the short arm of chromosome 17 and is one of the most studied genes in human biology due to its critical role in maintaining genomic stability. When a variant occurs in this gene, it can potentially alter the structure or function of the p53 protein, which acts as a tumor suppressor. Because TP53 is so vital, researchers pay close attention to any variations found within its sequence to determine if they disrupt the protein's ability to prevent uncontrolled cell growth. The rs121912619 variant is categorized as a rare finding, meaning it is not commonly observed in the general population, which often makes it more difficult for scientists to gather enough data to definitively classify its clinical impact.
The Role of the TP53 Gene
The TP53 gene provides instructions for making the p53 protein, often referred to as the 'guardian of the genome.' This protein functions primarily as a transcription factor, meaning it binds to specific sequences of DNA to turn other genes on or off. When cells experience stress—such as DNA damage, hypoxia, or oncogene activation—p53 is activated to initiate repair mechanisms, pause the cell cycle, or trigger programmed cell death (apoptosis) if the damage is too severe to fix. By preventing cells with damaged DNA from dividing, p53 acts as a powerful barrier against the development of cancer. Because of this essential function, variants that cause a complete loss of p53 activity are often associated with severe, highly penetrant cancer predisposition syndromes. However, not all variants result in a total loss of function; some, like hypomorphic alleles, retain partial activity, leading to more complex and less predictable clinical outcomes.
Research and Clinical Evidence
The clinical significance of rs121912619 has been a subject of scientific debate. Historically, this variant was sometimes flagged as pathogenic, leading to concerns about cancer risk. However, more recent research characterizes it as a hypomorphic allele. A hypomorphic variant is one that retains some, but not all, of the normal function of the gene. Unlike classic pathogenic variants that completely disable the p53 protein, hypomorphic variants often allow the protein to maintain intermediate transcriptional activity and growth-suppressive functions. This distinction is crucial because it suggests that the cancer risk associated with this variant may be significantly lower than that of high-penetrance mutations. Because evidence is still evolving, it is often classified as a variant of uncertain significance (VUS) or a low-penetrance variant in clinical databases. Researchers continue to study these variants to better understand how partial loss of function influences long-term health outcomes and to refine clinical guidelines for patients who carry them.
Population Frequency and Interpretation
The rs121912619 variant is considered rare across global populations. In genetic studies, rarity is a key factor in classification; when a variant is extremely uncommon, it is harder to perform large-scale statistical analyses to confirm its association with specific health conditions. Because of this, the variant is frequently identified in clinical settings as a secondary finding or during broad genetic screening. It is important to note that the presence of a rare variant does not automatically imply a high risk of disease. Geneticists must weigh multiple lines of evidence, including functional studies, family history, and population frequency, to determine if a variant is truly causative. For individuals who receive a report mentioning this variant, it is essential to understand that the current scientific consensus points toward a hypomorphic nature rather than a high-risk pathogenic one. Always consult with a genetic counselor or a medical professional to interpret these results within the context of your personal and family health history.
Navigating Genetic Information
Understanding your genetic data can be empowering, but it requires careful interpretation. If you have identified rs121912619 in your genetic report, it is important to recognize that this information is not a medical diagnosis. Genetic variants are only one piece of a much larger puzzle that includes your environment, lifestyle, and other genetic factors. You cannot change your genotype, but you can use this information to have informed conversations with your healthcare provider. If you are concerned about cancer risk, a genetic counselor can help you evaluate your family history and determine if further clinical testing or specialized screening is appropriate. Avoid making health decisions based solely on raw data from consumer genetic tests. Instead, rely on clinical-grade testing and professional medical guidance to navigate the complexities of your genetic profile. Remember that science is constantly evolving, and what is classified as a VUS today may be better understood as more research becomes available in the future.
How common is this variant?
The rs121912619 variant is rare in the general population, with most individuals carrying the common reference allele.
Frequently asked questions
Is rs121912619 a cancer-causing mutation?
While historically misclassified, current research suggests this variant is hypomorphic, meaning it retains partial function. It is not considered a high-penetrance mutation like those typically associated with Li-Fraumeni syndrome.
What does it mean if my report says I have this variant?
Finding this variant means you carry a rare genetic change in the TP53 gene. Because it is a hypomorphic allele, it is often classified as a variant of uncertain significance, and you should discuss the findings with a genetic counselor.
Should I be worried about my health if I have this SNP?
Genetic variants are only one factor in your overall health. You should not use this information to diagnose yourself; instead, share the report with your doctor to discuss your personal and family health history.
Where can I find more information about TP53 variants?
You can look at resources like ClinVar or the National Library of Medicine's MedlinePlus Genetics for reliable, peer-reviewed information on gene variants and their clinical significance.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912619?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
This pathogenic germline variant in the TP53 gene is associated with Li-Fraumeni syndrome, a condition characterized by a high risk of early-onset cancers.
Pathogenic missense variant (p.Arg248Gln) associated with Li-Fraumeni syndrome.
Functional codon 72 polymorphism (Arg72Pro) affecting apoptotic capability and associated with differential susceptibility to multiple cancer types.
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.
Pathogenic hotspot variant (p.Arg273His) in TP53 predisposing carriers to early-onset sarcomas, breast cancers, and leukemias.
Li-Fraumeni syndrome missense variant (p.Arg248Trp) causing loss of tumor suppressor function and multi-cancer predisposition.